The race to acquire Life Technologies (LIFE) looks to be back in full swing again, with KKR (KKR) reportedly mulling a joint bid with other private-equity firms for the biomedical laboratory equipment maker, which has a market cap of $10.5B. Strategic suitor Thermo Fisher Scientific (TMO) may renew its interest after backing off last month, while Danaher (DHR) is also sniffing around. A group led by Blackstone (BX) and Carlyle (CG) have been rumored to be in talks.
The race to acquire Life Technologies (LIFE) looks to be back in full swing again, with KKR...
From other sites
Video at CNBC.com (Jun 28, 2016)
Video at CNBC.com (May 27, 2016)
Video at CNBC.com (Apr 7, 2016)
at CNBC.com (Nov 5, 2014)
at CNBC.com (Oct 22, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs